Parallel Advisors’s Vicarious Surgical RBOT Stock Holding History

Parallel Advisors’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$18	–	3443
2023 Q3	$18	Hold	1	–	–	﹤0.01%	3326
2023 Q2	$55	Hold	1	–	–	﹤0.01%	3309
2023 Q1	$68	Sell	1 -4	-80%	-$311	﹤0.01%	3357
2022 Q4	$273	Buy	5 +4	+400%	+$372	﹤0.01%	3138
2022 Q3	$0	Hold	1	–	–	﹤0.01%	3429
2022 Q2	$0	Buy	+1	New	+$122	﹤0.01%	3286
2021 Q3	–	Sell	-1	Closed	–	–	3235
2021 Q2	$0	Buy	+1	New	+$298	﹤0.01%	3039

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

MAMHA

MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return

DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Parallel Advisors's RBOT Position: Q4 2023 in Review

Parallel Advisors sold out of Vicarious Surgical (RBOT) in Q4 2023, closing a stake of 1 share — an estimated $18 sold.

Parallel Advisors first reported a position in RBOT in Q2 2021 and held it in 7 quarters. The position peaked at $273 in Q4 2022. 72 funds tracked by Wall St. Rank hold RBOT as of Q4 2023.

Parallel Advisors reported no remaining Vicarious Surgical position as of Q4 2023 after selling out during the quarter.
Parallel Advisors sold 1 Vicarious Surgical share in Q4 2023, an estimated $18.
Parallel Advisors first reported a position in Vicarious Surgical in Q2 2021 and held it in 7 quarters.
Parallel Advisors's Vicarious Surgical position peaked at $273 in Q4 2022.
72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2023.

Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.